Youcai An

Ab&b Bio-tech Co., Ltd

SCHOLARLY PAPERS

1

DOWNLOADS

25

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Randomized, Blind, Parallel Controlled Phase I Clinical Trial to Evaluate the Safety and Preliminary Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy People Aged 2 Years and Older

Number of pages: 30 Posted: 05 Dec 2023
Ab&b Bio-tech Co., Ltd, Government of the People's Republic of China - National Institutes for Food and Drug Control, Ab&b Bio-tech Co., Ltd, Ab&b Bio-tech Co., Ltd, Ab&b Bio-tech Co., Ltd, Ab&b Bio-tech Co., Ltd, Zhengzhou University, Henan Provincial Center for Disease Control Prevention, Henan Provincial Center for Disease Control Prevention, Ab&b Bio-tech Co., Ltd, Ab&b Bio-tech Co., Ltd, Henan Provincial Center for Disease Control Prevention, affiliation not provided to SSRN, Ab&b Bio-tech Co., Ltd, Ab&b Bio-tech Co., Ltd, Ab&b Bio-tech Co., Ltd, Zhengzhou University, Henan Provincial Center for Disease Control Prevention, Ab&b Bio-tech Co., Ltd and Ab&b Bio-tech Co., Ltd
Downloads 25 (1,101,479)

Abstract:

Loading...

Streptococcus pneumoniae;Safety;Immunogenicity;23-valent pneumococcal polysaccharide vaccine;Clinical trial